Advocacy intelligence hub — real-time data for patient organizations
Amgen — PHASE3
Emory University — PHASE1, PHASE2
Adichunchanagiri Institute of Medical Sciences, B G Nagara — NA
Adichunchanagiri Institute of Medical Sciences, B G Nagara — NA
Angitia Incorporated Limited — PHASE2
Meyer Children's Hospital IRCCS — NA
Suez Canal University — NA
University Hospital, Ghent — NA
Istituto Ortopedico Rizzoli
Universidad de Especialidades Espiritu Santo — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Luca Sangiorgi, PhD
Istituto Ortopedico Rizzoli
Cathleen Raggio, MD, M.D
Hospital for Special Surgery, New York
📍 UNIONDALE, NY
Eva Åström, MD PhD
Karolinska University Hospital
Thomas EDOUARD, MD
University Hospital, Toulouse
📍 Montpellier
Ultragenyx Medical Director
Ultragenyx Pharmaceuticals Inc.
📍 Little Rock, Arkansas
Ann Zovein, MD
Angitia Incorporated Limited
📍 SAN FRANCISCO, CA